MKI67 and neoplasm: There were no significant differences between the two groups in terms of gender, age (year), ECOG-PS score, tumor site, tumor size, gastrectomy, pathological differentiation, pT stage, pTNM stage, lauren type, elevated CEA, CA19-9, CA72-4 proportion, and Ki-67–positive rate (P > 0.05, Table 1).